The Hindu Business Line : Dr Reddy's launches drug for diarrhoea

DR Reddy's Laboratories has announced the launch of Redotil (racecadotril), claimed to be the first anti-hypersecretory agent for the management of acute diarrhoea in the country. In a press release here on Friday, the company said the product would be available in 100 mg capsules.

Commenting on the launch, Dr Reddy's President, Branded Formulations Business, Mr Jaspal Singh Bajwa, said, "Redotil addresses a critical need of the medical fraternity across the country. Redotil's unique mechanism of action and quick control of diarrhoea makes it a novel drug in this therapeutic category."

About one million diarrhoea-related deaths occur each year in South-East Asia.

The product is an important addition to the company's gastrointestinal product portfolio.

More Stories on : New Products & Services | Health | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Cobra in pact with Mount Shivalik

Business Line quiz to be held across three cities

Thums Up offers `Mega Thunder' in AP

HLL ties up with CESC to promote new Pepsodent

UB group edges out Bacardi as fourth largest spirit marketer

Arrow to retail in new format

Liberty group plans retail Revolutions

Grey study on home-makers busts stereotypes

V.I.P. buys out Carlton brand of UK

Dr Reddy's launches drug for diarrhoea